comparemela.com

Latest Breaking News On - Opposition research - Page 1 : comparemela.com

Transcripts For CSPAN3 Former Deputy FBI Director Andrew McCabe Testifies On Review Of FBI Russia... 20240711

Welcome, everybody. I think we have some republicans that have a leadership election, but theyll be coming in. Can you see me . Can you hear me . Is it working . Well, the election is over. Theyre still counting the votes and making legal challenges and once all of the legal challenges are made and the votes are counted, well have that done. We still have two outstanding races in georgia to determine the control of the senate. And the committee will keep moving forward doing its work. We have next week social media oversight. I cant wait to have the social media ceos come to the committee and explain themselves about their platforms. I think theres a lot of bipartisan support to take a hard look at social media platforms. The earned act is still a business pending before the committee and after the hearing well have markup. But today, we have mr. Mccabe, the number two at the fbi during crossfire hurricane. I think hes going to appear remotely. I appreciate him coming. And what ill do

Arizona
United-states
Georgia
Australia
South-carolina
Texas
Washington
China
Whitehouse
District-of-columbia
Russia
Wuhan

Transcripts For CSPAN3 Former Deputy FBI Director Andrew McCabe Testifies On Review Of FBI Russia... 20240711

Welcome, everybody. I think we have some leadership, about the theyll be coming in. Can you see, can you hear me . Is it working . Well, the election is over. Theyre still counting the votes and making legal challenges, and once all the legal challenges are made and the votes are counted, well have that done. Weve still got two outstanding races in georgia to determine the control of the senate and the committee will keep moving forward doing its work. We have next week social media oversight. I cant wait to have the social media ceos come to the committee and explain themselves about their platform, thats the 17th. I think theres a lot of bipartisan support to take a hard look at social media platform. The act is still business pending before the committee and after the hearing well have markup. But today we have mr. Mccabe, the number two at the fbi during the hurricane. I think hes going to appear remotely, so i appreciate him coming. And what ill do is make a brief Opening Statemen

Georgia
United-states
Australia
Texas
Washington
China
Whitehouse
District-of-columbia
California
Virginia
Russia
London

Transcripts For CNN New Day With Alisyn Camerota and John Berman 20240711

Against the variants right now. The more contagious variant first found in south africa is here. It almost certainly means theres other cases out there. This is new day, with Alisyn Camerota and john berman. Welcome to our viewers in the United States and all around the world. This is new day. It is friday, january 29th, its 6 00 here in new york. So why is this man smiling . No, not the guy on the left who lost an election by 7 million votes and presided over the deaths of 400,000 americans from coronavirus. The guy on the right, the republican leader on the right. Why is he smiling . Because hes been working on some bipartisan deal to get vaccines to millions of people . Is he smiling because hes been fighting for Economic Relief for millions of people out of work . Is he smiling because hes taken a new public stand against lies, hate, and bigotry . No, no, and no. Hes smiling because he got a political pat on the head, the tender embrace of the man who told a mob to march on the cap

Republican-party
Battle-with-coronavirus
Trump
Soul
Impeachment-trial
Kevin-mccarthy
Variants
Constitution
Identity-crisis
Center
Race
Variant

Transcripts For CNN New Day With Alisyn Camerota and John Berman 20240711

Elizabeth cohen. She joins us with the breaking details. What do you have, elizabeth . Alisyn, so the bottom line here is that we may soon have a third vaccine in the United States. We already have pfizer, moderna and with these results, its almost certain Johnson Johnson will be applying for Emergency Use Authorization from the fda. The bottom line, this vaccine does not seem to be as effective as pfizer or moderna but has impressive results and is still useful. Lets go over these specific numbers. The Johnson Johnson trial data shows that when you are looking at moderate to severe cases of covid19, it was 66 effective at putting preventing those, whereas moderna and pfizer was 95 . Those two were 95 . Thats a significant difference. If you look at preventing severe cases of covid19, which is the more important one, right . We dont want people in the hospital. We dont want people in the icu or dying. Johnson johnson was 85 effective at preventing severe cases. Moderna and pfizer were

Breaking-news
Cnn
Many
Johnson
Vaccine
Data
Dose
Ones
Doses
Phase-three-trial
Battle-against-coronavirus
Two

Transcripts For CNN The Lead With Jake Tapper 20240711

In which you start to see efficacy anywhere from seven to ten days following the first and only shot. It is very, very good with regard to cold chain requirements, requiring only a refrigerator. It is inexpensive, and the company is capable of making doses in the numbers of billions. While the White House Task force is focused on the Vaccination Piece of this pandemic, President Biden is working today to help americans suffering financially. He is urging republicans to get on board with his 1. 9 trillion Relief Package. So the choice couldnt be clearer. We have learned from past crises the risk is not doing too much. The risk is not doing enough. The congress isnt just divided over the relief bill. The Republican Party is showing more signs of fracture as former preponderance of the evidence donald trump seems to be keeping a firm grip on a number of people in the party, and well dive into that in just a little bit. First, Johnson Johnsons new singleshot vaccine, its advantages and dis

News
Thanks
Brooke-baldwin
Cnn
Pursuit
Vaccines
Johnson
Disease
Results
Covid-19
Vaccination
Trial

vimarsana © 2020. All Rights Reserved.